Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice
Vincent A. Pollack, Douglas M. Savage, Deborah A. Baker et al. · Journal of Pharmacology and Experimental Therapeutics · 1999
Cited by 434 works. doi:10.1016/s0022-3565(24)35162-6
Authors
- Vincent A. Pollack
- Douglas M. Savage
- Deborah A. Baker
- Konstantinos E. Tsaparikos
- Donald E. Sloan
- James D. Moyer
- Elsa G. Barbacci-Tobin
- Leslie R. Pustilnik
- Teresa A. Smolarek
- John A. Davis
- M.C. Vaidya
- Lee D. Arnold
- John L. Doty
- Kenneth K. Iwata
- Michael J. Morin
References
- Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells.
- PROTOCOLS FOR SCREENING CHEMICAL AGENTS AND NATURAL PRODUCTS AGAINST ANIMAL TUMORS AND OTHER BIOLOGICAL SYSTEMS
- Increase of the Catalytic Activity of Phospholipase C-γ1 by Tyrosine Phosphorylation
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells
- BindingDB Entry 50022536: Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.
- Epidermal-Growth-Factor-Dependent Transformation by a Human EGF Receptor Proto-Oncogene
- A point mutation at the ATP‐binding site of the EGF‐receptor abolishes signal transduction.
- EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS
- Tyrosine kinase activity is essential for the association of phospholipase C-gamma with the epidermal growth factor receptor.
- Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.